Multidrug Resistant Pseudomonas aeruginosa in Clinical Settings: A Review of Resistance Mechanisms and Treatment Strategies
Top Cited Papers
Open Access
Abstract
Pseudomonas aeruginosa is causing increasing concern among clinicians due to its high mortality and resistance rates. This bacterium is responsible for various infections, especially in hospital settings, affecting some of the most vulnerable patients. Pseudomonas aeruginosa has developed resistance through multiple mechanisms, making treatment challenging. Diagnostic techniques are evolving, with rapid testing systems providing results within 4–6 h. New antimicrobial agents are continuously being developed, offering potential solutions to these complex clinical decisions. This article provides a review of the epidemiology, at-risk populations, resistance mechanisms, and diagnostic and treatment options for Pseudomonas aeruginosa.Keywords
This publication has 90 references indexed in Scilit:
- Surgical site infections caused by multi-drug resistant organisms: a case–control study in general surgeryUpdates in Surgery, 2022
- Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosaInfectious Diseases and Therapy, 2022
- Microbial Epidemiology of Infectious Endocarditis in the Intravenous Drug Abuse Population: A Retrospective StudyInfectious Diseases and Therapy, 2019
- Development and Assessment of Risk Scores for Carbapenem and Extensive β-Lactam Resistance Among Adult Hospitalized Patients WithPseudomonas aeruginosaInfectionJAMA Network Open, 2018
- Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical TrialInfectious Diseases and Therapy, 2018
- Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract InfectionJAMA, 2018
- Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor CombinationDrugs, 2013
- Growth and Laboratory Maintenance of Pseudomonas aeruginosaCurrent Protocols in Microbiology, 2012
- Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with gram‐negative bacteremiaJournal of Hospital Medicine, 2011
- Pseudomonas aeruginosa biofilms: role of the alginate exopolysaccharideJournal of Industrial Microbiology and Biotechnology, 1995